FSD Pharma Inc. (HUGE)
0.09
-0.01 (-10.00%)
At close: Aug 14, 2024, 8:00 PM
Company Description
FSD Pharma Inc., through its subsidiaries, operates as a pharmaceutical research and development company.
Its lead candidate includes FSD-201 that is in the Phase II clinical trial to treat COVID-19 disease.
The company also focuses on Lucid-PSYCH, a psychoactive molecule identified for the potential treatment of neuropsychiatric disorders, such as depressive disorder; and Lucid-MS, a patented new chemical entity shown to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models.
FSD Pharma Inc. was founded in 1998 and is headquartered in Toronto, Canada.
FSD Pharma Inc.
| Country | CA |
| IPO Date | Jun 8, 2018 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 17 |
| CEO | Zeeshan Saeed |
Contact Details
Address: 199 Bay Street Toronto, ON CA | |
| Website | https://www.fsdpharma.com |
Stock Details
| Ticker Symbol | HUGE |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001771885 |
| CUSIP Number | 35954B206 |
| ISIN Number | CA35954B4047 |
| Employer ID | 00-0000000 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Dr. Lakshmi P. Kotra BPHARM, Ph.D. | Chief Executive Officer of Lucid & Director |
| Zeeshan Saeed | Founder, Chief Executive Officer, President & Executive Co-Chairman |
| Donal Carroll CPA | Chief Operating Officer |
| Nathan Coyle CPA | Chief Financial Officer |
| Anthony John Durkacz | Founder & Executive Co-Chairman |
| Dr. Andrzej Chruscinski M.D., Ph.D. | Vice President of Clinical & Scientific Affairs of Lucid |
| Kevin Cassidy | Vice President of Quality-Lucid |
| Maryann Adesso | Corporate Secretary |
| Randell Mack | President of FSD BioSciences |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 21, 2025 | 6-K | Filing |
| Apr 14, 2025 | 6-K | Filing |
| Apr 10, 2025 | 6-K | Filing |
| Apr 03, 2025 | 6-K | Filing |
| Apr 01, 2025 | 6-K | Filing |
| Mar 31, 2025 | 20-F/A | [Amend] Filing |
| Mar 31, 2025 | 6-K | Filing |
| Mar 28, 2025 | 20-F | Filing |
| Mar 28, 2025 | 6-K | Filing |
| Mar 27, 2025 | 6-K | Filing |